Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today ...

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.

Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...

Researchers at The University of Manchester are developing miniature soft robots designed to deliver anti-cancer drugs directly to tumors in the bowel. The project, backed by nearly £1 million in ...

A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...

Nanotechnology in drug delivery offers key market opportunities by enhancing drug precision, targeting challenging diseases, and improving patient care. The growing adoption is fueled by advancements ...

Pancreatic cancer has long sat among oncology’s most difficult frontiers — a disease where survival rates remain stubbornly ...

A year after an FDA rejection, Johnson & Johnson has won approval for a more convenient version of its lung cancer drug Rybrevant to better challenge AstraZeneca’s Tagrisso. Rybrevant Faspro, a ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

The global Microneedle Drug Delivery Systems Market is projected to grow from USD 0.8 billion in 2026 to USD 1.6 billion by 2036, expanding at a CAGR ...